OLEA 105 - MeDAL | Breast

metastatic diagnostics, access & literacy | breast cancers

Status

MeDAL | Breast is actively recruiting the OLEA working group. The initiative anticipates finalize its scope in June 2023.
Click below to inquire about OLEA 105 - MeDAL | Breast.

Objectives

  1. improve the ability for metastatic breast cancer patients to ask for biomarker testing through a tailored and co-created digital literacy intervention

  2. assess impact of biomarker literacy program on loved ones of patients

Digital Co-Creation

MeDAL | Breast will improve optimize the learn module for breast cancer patients and their loved ones to educate on biomarker literacy. Following deep listening sessions, patient and caregiver working group participants will co-create the biomarker learning journey on myRabble in an effort to improve shared decision making.

WORKING GROUP:

OLEA 105 - MeDAL | Breast

  • Medical Lead - Open

    partner with patient advocacy and alliance mgmt to oversee the conduct the development, implementation, and publications for OLEA 102

  • Patient Lead - Open

    local patient advocacy organization which partners with medical and alliance mgmt to oversee the conduct, development, implementation, and publications for OLEA 102

  • Community Member - Open

    partnering organization which extends community participation of the initiative to achieve sustainable benefit for the community as a whole

Join the effort

ABCD | Memphis is actively seeking sponsors and community partners to scale the initiative. Click below to inquire further.

Previous
Previous

OLEA 104 - MeDAL | CRC

Next
Next

OLEA 106 - ACT | Breast